| Robert William Koss, MD | |
|
12902 Usf Magnolia Dr, Tampa, FL 33612-9416 | |
| (813) 745-4673 | |
| Not Available |
| Full Name | Robert William Koss |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 12902 Usf Magnolia Dr, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003902701 | NPI | - | NPPES |
| 045279300 | Medicaid | FL | |
| 02113 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME49059 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert William Koss, MD 5202 Culasaja Cir, Valrico, FL 33596-8265 Ph: (813) 684-7663 | Robert William Koss, MD 12902 Usf Magnolia Dr, Tampa, FL 33612-9416 Ph: (813) 745-4673 |
News Archive
A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.
One day soon, doctors may determine how physically active you are simply by imaging your brain. Physically fit people tend to have larger brain volumes and more intact white matter than their less-fit peers. Now a new study reveals that older adults who regularly engage in moderate to vigorous physical activity have more variable brain activity at rest than those who don't. This variability is associated with better cognitive performance, researchers say.
UT Southwestern Medical Center researchers have discovered a mutation that causes a rare systemic disorder known as X-linked reticulate pigmentary disorder (XLPDR) and, significantly, the unexpected cellular mechanism by which the mutation causes the disease.
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
› Verified 7 days ago
Ashok Narayan Shenoy, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Tampa General Cir, Suite A327, Tampa, FL 33606 Phone: 813-844-7677 Fax: 813-844-4972 | |
Satish Bollu Reddy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2727 W Dr Martin Luther King Jr Blvd, Suite 310, Tampa, FL 33607 Phone: 813-350-7244 Fax: 813-350-7246 | |
Dr. Jeffrey Marc Gilfor, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11911 N Dale Mabry Hwy, Tampa, FL 33618 Phone: 813-265-5300 | |
William Joseph Quartuccio, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2 Columbia Dr, Suite: A-327, Tampa, FL 33606 Phone: 813-844-4396 Fax: 813-844-4972 | |
Carla Elaine Galang, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2 Columbia Dr, Suite A327, Tampa, FL 33606 Phone: 813-844-4396 Fax: 813-844-7942 | |
Jay A Reichbach, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4211 W Boy Scout Blvd, Suite 400, Tampa, FL 33607 Phone: 855-485-3262 Fax: 813-443-8255 |